448 related articles for article (PubMed ID: 28272374)
1. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Palmini G; Marini F; Brandi ML
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
[TBL] [Abstract][Full Text] [Related]
2. Review of microRNA in osteosarcoma and chondrosarcoma.
Chang L; Shrestha S; LaChaud G; Scott MA; James AW
Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
[TBL] [Abstract][Full Text] [Related]
3. microRNA and Bone Cancer.
Nugent M
Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
[TBL] [Abstract][Full Text] [Related]
4. The miRNAs in the pathgenesis of osteosarcoma.
Liang W; Gao B; Fu P; Xu S; Qian Y; Fu Q
Front Biosci (Landmark Ed); 2013 Jan; 18(2):788-94. PubMed ID: 23276964
[TBL] [Abstract][Full Text] [Related]
5. Experimental therapies and clinical trials in bone sarcoma.
Chugh R
J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301
[TBL] [Abstract][Full Text] [Related]
6. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
7. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.
van Oosterwijk JG; Anninga JK; Gelderblom H; Cleton-Jansen AM; Bovée JV
Hematol Oncol Clin North Am; 2013 Oct; 27(5):1021-48. PubMed ID: 24093174
[TBL] [Abstract][Full Text] [Related]
8. Pelvic bone sarcomas: controversies and treatment options.
Morris CD
J Natl Compr Canc Netw; 2010 Jun; 8(6):731-7. PubMed ID: 20581302
[TBL] [Abstract][Full Text] [Related]
9. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
[TBL] [Abstract][Full Text] [Related]
10. Historical, current and future aspects of osteosarcoma treatment.
Ham SJ; Schraffordt Koops H; van der Graaf WT; van Horn JR; Postma L; Hoekstra HJ
Eur J Surg Oncol; 1998 Dec; 24(6):584-600. PubMed ID: 9870738
[No Abstract] [Full Text] [Related]
11. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
13. microRNAs and bone tumours: Role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing's sarcoma.
Palmini G; Brandi ML
Bone; 2021 Aug; 149():115968. PubMed ID: 33892177
[TBL] [Abstract][Full Text] [Related]
14. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
15. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
16. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
[TBL] [Abstract][Full Text] [Related]
17. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
Ram Kumar RM; Boro A; Fuchs B
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
[TBL] [Abstract][Full Text] [Related]
18. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.
Dai X; Ma W; He X; Jha RK
Med Sci Monit; 2011 Aug; 17(8):RA177-190. PubMed ID: 21804475
[TBL] [Abstract][Full Text] [Related]
19. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Lin Z; Xie X; Lu S; Liu T
Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
[TBL] [Abstract][Full Text] [Related]
20. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.
Izadpanah S; Shabani P; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
Biomed Pharmacother; 2019 Mar; 111():873-881. PubMed ID: 30841466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
